AEMD vs PRTH

Priority Technology Holdings, Inc.

(PRTH) offers the better valuation at 8. 1x trailing P/E (5. 8x forward), making it the more compelling value choice. Analysts rate Priority Technology Holdings, Inc. (PRTH) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Priority Technology Holdings, Inc.

(PRTH) delivered a total return of -15. 9%, compared to -99. 8% for Aethlon Medical, Inc. (AEMD). Over 10 years, the gap is even starker: PRTH returned -43. 8% versus AEMD's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Aethlon Medical, Inc.

(AEMD) is the lower-risk stock at 1. 46β versus Priority Technology Holdings, Inc. 's 2. 12β — meaning PRTH is approximately 45% more volatile than AEMD relative to the S&P 500.

On earnings-per-share growth, the picture is similar: Priority Technology Holdings, Inc.

grew EPS 319. 4% year-over-year, compared to -76. 5% for Aethlon Medical, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Priority Technology Holdings, Inc.

(PRTH) is the more profitable company, earning 5. 8% net margin versus 0. 0% for Aethlon Medical, Inc. — meaning it keeps 5. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRTH leads at 14. 8% versus 0. 0% for AEMD. At the gross margin level — before operating expenses — PRTH leads at 21. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Aethlon Medical, Inc.

(AEMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Priority Technology Holdings, Inc. (PRTH) carries a higher beta of 2. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AEMD: -100. 0%, PRTH: -43. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AEMD (Healthcare) and PRTH (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AEMD is a small-cap quality compounder stock; PRTH is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.